Open access · OA
via Europe PMC
NAD+ signaling in Parkinson's disease: molecular mechanisms and therapeutic perspectives
Frontiers in neurology
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
T, W., X, Z., & X., C. (n.d.). NAD+ signaling in Parkinson's disease: molecular mechanisms and therapeutic perspectives. <em>Frontiers in neurology</em>. https://europepmc.org/article/PMC/PMC13663023
Vancouver
T W, X Z, X. C. NAD+ signaling in Parkinson's disease: molecular mechanisms and therapeutic perspectives. Frontiers in neurology.
BibTeX
@article{wangndNADsig,
title = {NAD+ signaling in Parkinson's disease: molecular mechanisms and therapeutic perspectives},
author = {Wang T and Zhou X and Chen X.},
journal = {Frontiers in neurology},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The Lancet 2009
Citation only
Parkinson's disease
The Lancet 2021
Open access · OA
Parkinson's disease
Pharmacological Research 2008
Preprint · OA
α-Synuclein: A therapeutic target for Parkinson’s disease?
Journal of Neural Transmission 2000
Citation only
Cell death mechanisms in Parkinson's disease
International journal of molecular sciences 2026
Open access · OA
Cellular Senescence in Ocular Surface Diseases: Molecular Mechanisms and Therapeutic Perspectives
Molecular and Cellular Biochemistry 2022
Preprint · OA